Latest Insider Transactions at Cardiovascular Systems Inc (CSII)
This section provides a real-time view of insider transactions for Cardiovascular Systems Inc (CSII). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Cardiovascular Systems Inc to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Cardiovascular Systems Inc's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 27
2023
|
Scott R. Ward Chairman and CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
811,022
-85.65%
|
$16,220,440
$20.0 P/Share
|
|
Apr 27
2023
|
Alexander Rosenstein General Counsel & Corp. Sec. |
SELL
Sale (or disposition) back to the issuer
|
Direct |
148,673
-86.22%
|
$2,973,460
$20.0 P/Share
|
|
Apr 27
2023
|
William E. Cohn Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
9,449
-100.0%
|
$188,980
$20.0 P/Share
|
|
Apr 27
2023
|
Stephen Stenbeck Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
3,153
-100.0%
|
$63,060
$20.0 P/Share
|
|
Apr 27
2023
|
Augustine Lawlor Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
25,318
-100.0%
|
$506,360
$20.0 P/Share
|
|
Apr 27
2023
|
Augustine Lawlor Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
5,022
-100.0%
|
$100,440
$20.0 P/Share
|
|
Apr 27
2023
|
Martha Goldberg Aronson Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
12,411
-100.0%
|
$248,220
$20.0 P/Share
|
|
Apr 27
2023
|
Sandra Sedo Chief Compliance Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
114,384
-85.79%
|
$2,287,680
$20.0 P/Share
|
|
Apr 27
2023
|
Stephen J. Rempe Chief Human Resources Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
84,220
-94.92%
|
$1,684,400
$20.0 P/Share
|
|
Apr 27
2023
|
Jeffrey S. Points Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
173,008
-90.16%
|
$3,460,160
$20.0 P/Share
|
|
Apr 27
2023
|
Erik Paulsen Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
700
-100.0%
|
$14,000
$20.0 P/Share
|
|
Feb 13
2023
|
Sandra Sedo Chief Compliance Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,077
+4.25%
|
-
|
|
Feb 13
2023
|
Scott R. Ward Chairman and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
5,077
+0.62%
|
-
|
|
Feb 13
2023
|
Stephen J. Rempe Chief Human Resources Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,077
+5.69%
|
-
|
|
Feb 13
2023
|
Alexander Rosenstein General Counsel & Corp. Sec. |
BUY
Grant, award, or other acquisition
|
Direct |
5,077
+3.3%
|
-
|
|
Feb 13
2023
|
Jeffrey S. Points Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,077
+2.85%
|
-
|
|
Feb 12
2023
|
Sandra Sedo Chief Compliance Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
984
-0.89%
|
$18,696
$19.7 P/Share
|
|
Feb 12
2023
|
Scott R. Ward Chairman and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,493
-0.18%
|
$28,367
$19.7 P/Share
|
|
Feb 12
2023
|
Stephen J. Rempe Chief Human Resources Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
984
-1.24%
|
$18,696
$19.7 P/Share
|
|
Feb 12
2023
|
Alexander Rosenstein General Counsel & Corp. Sec. |
SELL
Payment of exercise price or tax liability
|
Direct |
984
-0.68%
|
$18,696
$19.7 P/Share
|
|
Feb 12
2023
|
Jeffrey S. Points Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
984
-0.58%
|
$18,696
$19.7 P/Share
|
|
Nov 12
2022
|
Sandra Sedo Chief Compliance Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
267
-0.24%
|
$3,738
$14.67 P/Share
|
|
Aug 18
2022
|
Stephen J. Rempe Chief Human Resources Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
6,175
-7.22%
|
-
|
|
Aug 18
2022
|
Scott R. Ward Chairman and CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
77,028
-8.71%
|
-
|
|
Aug 18
2022
|
Jeffrey S. Points Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
12,752
-7.02%
|
-
|
|
Aug 18
2022
|
Alexander Rosenstein General Counsel & Corp. Sec. |
SELL
Sale (or disposition) back to the issuer
|
Direct |
10,955
-7.04%
|
-
|
|
Aug 18
2022
|
Sandra Sedo Chief Compliance Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
9,873
-8.2%
|
-
|
|
Aug 15
2022
|
Martha Goldberg Aronson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,411
+16.27%
|
-
|
|
Aug 12
2022
|
Stephen J. Rempe Chief Human Resources Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,005
-2.29%
|
$32,080
$16.64 P/Share
|
|
Aug 12
2022
|
Scott R. Ward Chairman and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
16,006
-1.78%
|
$256,096
$16.64 P/Share
|
|
Aug 12
2022
|
Sandra Sedo Chief Compliance Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,942
-1.59%
|
$31,072
$16.64 P/Share
|
|
Aug 12
2022
|
Alexander Rosenstein General Counsel & Corp. Sec. |
SELL
Payment of exercise price or tax liability
|
Direct |
2,601
-1.64%
|
$41,616
$16.64 P/Share
|
|
Aug 12
2022
|
Jeffrey S. Points Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,308
-1.79%
|
$52,928
$16.64 P/Share
|
|
Aug 12
2022
|
John M. Hastings VP Manufacturing & Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
1,628
-2.95%
|
$26,048
$16.64 P/Share
|
|
Aug 05
2022
|
Scott R. Ward Chairman and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
319,759
+15.91%
|
-
|
|
Aug 05
2022
|
Jeffrey S. Points Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
75,663
+18.17%
|
-
|
|
Aug 05
2022
|
Stephen J. Rempe Chief Human Resources Officer |
BUY
Grant, award, or other acquisition
|
Direct |
37,903
+19.18%
|
-
|
|
Aug 05
2022
|
Alexander Rosenstein General Counsel & Corp. Sec. |
BUY
Grant, award, or other acquisition
|
Direct |
57,387
+16.24%
|
-
|
|
Aug 05
2022
|
Sandra Sedo Chief Compliance Officer |
BUY
Grant, award, or other acquisition
|
Direct |
41,027
+15.08%
|
-
|
|
Aug 05
2022
|
William E. Cohn Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,626
+27.73%
|
-
|
|
May 20
2022
|
Scott R. Ward Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
3,000
+0.51%
|
$42,000
$14.49 P/Share
|
|
May 20
2022
|
Jeffrey S. Points Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
3,000
+2.67%
|
$42,000
$14.5 P/Share
|
|
May 12
2022
|
Stephen J. Rempe Chief Human Resources Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
226
-0.45%
|
$3,390
$15.33 P/Share
|
|
Feb 23
2022
|
Erik Paulsen Director |
BUY
Open market or private purchase
|
Direct |
500
+41.67%
|
$9,500
$19.05 P/Share
|
|
Feb 08
2022
|
Jeffrey S. Points Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,477
+4.9%
|
-
|
|
Feb 08
2022
|
Jeffrey S. Points Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
2,000
+1.94%
|
$36,000
$18.2 P/Share
|
|
Feb 08
2022
|
Alexander Rosenstein General Counsel & Corp. Sec. |
BUY
Grant, award, or other acquisition
|
Direct |
5,477
+5.16%
|
-
|
|
Feb 08
2022
|
Sandra Sedo Chief Compliance Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,477
+6.31%
|
-
|
|
Feb 08
2022
|
Ryan Egeland Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,477
+6.71%
|
-
|
|
Feb 08
2022
|
John M. Hastings VP Manufacturing & Operations |
BUY
Grant, award, or other acquisition
|
Direct |
5,477
+9.01%
|
-
|